Company / FCF Margin
CASTLE BIOSCIENCES INC FCF Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
8.2%
FY2025
5-year range
-34.5% / 11.0%
FY2021-FY2025
Trend
-25.2%
vs FY2024
Sector context
#69 of 144
Health Care
What the data says
At 8.2%, CASTLE BIOSCIENCES INC's fcf margin ranks #69 of 144 in the Health Care sector. Improved from -8.8% to 8.2% over the past 2 years.
Based on SEC 10-K filings.
8.2% in FY2025 with a 5-year CAGR of +0.1%.
Improved from -8.8% to 8.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +42.7pp
- 5-Year Change
- +0.1pp
- 10-Year Change
- -
Sector benchmark
#69 of 144 in Health CareTop 48% of 144This company 8.2% Sector average -209.0%
▼
+103.9% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 25.2% year-over-year.
- Currently 217.3pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.2% | -25.2% |
| FY2024 | 11.0% | +225.6% |
| FY2023 | -8.8% | +74.6% |
| FY2022 | -34.5% | -44.5% |
| FY2021 | -23.9% | -392.6% |
| FY2020 | 8.2% | -30.4% |
| FY2019 | 11.7% | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026